Addition of Rituximab to Chemotherapy for Pediatric High-Risk, Mature B-Cell NHL
For pediatric high-risk B-cell NHL, adding rituximab to standard LMB chemotherapy prolongs event-free and overall survival but may increase adverse events.
Non-Hodgkin Lymphoma
High-Intensity RIC-NMAC Regimen Associated With Greater Mortality Risk in Allogeneic Transplant NHL
High-intensity RIC-NMAC regimen Flu-Mel140, may be linked to higher nonrelapse mortality in patients with NHL undergoing allogeneic transplantation.
Oxaliplatin May Reduce Nephrotoxicity Compared With Cisplatin in B-Cell Lymphoma
Researchers compared the efficacy and nephrotoxicity of R-DHAP vs R-DHAOx among patients treated for NHL between 2007 and 2014.
Autologous Stem Cell Transplantation Outcomes in Multiple Myeloma vs Non-Hodgkin Lymphoma
Higher graft CD34+ cell content is linked to improved platelet and neutrophil recovery after high-dose therapy.
Hypercalcemia as a Biomarker for Biological Aggressiveness of Diffuse Large B-Cell Lymphoma
Hypercalcemia is not uncommon in patients with de novo diffuse large B-cell lymphoma and may be linked to a higher risk for other adverse events.
Review of Features, Treatment Options in Peripheral T-Cell Lymphoma
Combined targeted agents with immune regulators and chimeric antigen receptor cell–based therapies may improve overall survival for patients with PTCL.
Roles of Nurse Practitioner and Nurse Navigator in a CAR-T Therapy Program at a Large Academic Oncology Center
Hands-on roles initially played by nurse navigators and nurse practitioners in the delivery of CAR-T cell therapy have evolved into resource/care coordination roles.
No Change in Transplant Outcomes for DLBCL With Addition of Rituximab to Conditioning
Overall survival, progression-free survival, and nonrelapse mortality were found to be similar in patients receiving BEAM conditioning with or without rituximab.
Intensive Immunochemotherapy May Yield Positive Outcomes in Burkitt Lymphoma
Researchers assessed data from Australian population-based lymphoma registries to determine the efficacy of intensive immunochemotherapy for Burkitt lymphoma.
Nitrite Consumption May Up Risk for Non-Hodgkin Lymphoma
Nitrite intake linked to carcinogenicity leading to NHL, development of diffuse large B cell lymphoma.
-
Loading...
-
Loading...
